Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cell Biology Proteolysis / Ubiquitin Proteolytic enzymes Metalloprotease ACEs

Recombinant Human ACE2 protein (Fc Chimera) (ab273687)

Price and availability

385 296 ₸

Availability

Order now and get it on Thursday February 25, 2021

Recombinant Human ACE2 protein (Fc Chimera) (ab273687)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: HEK 293 cells
  • Purity: > 95% Affinity purified
  • Endotoxin level:
  • Tags: Fc tag C-Terminus
  • Suitable for: SDS-PAGE, HPLC, ELISA

You may also be interested in

Product image
Mouse ACE2 ELISA Kit (ab213843)
Product image
Recombinant human ACE2 protein (Active) (ab277810)
Product image
Anti-ACE2 antibody [EPR4436] (ab108209)
Product image
Recombinant Human ACE2 (mutated H374N + H378N) protein (Fc Chimera) (ab273885)

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C.

    Constituent: PBS

Images

  • ELISA - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)
    ELISA - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)

    RBD Fc binding to immobilized ACE2 Fc fusion proteins. 96-well plates were coated with ab273687 and Recombinant Human ACE2 (mutated H374 N + H378 N) protein (Fc Chimera) (ab273885) at 5 µg/ml. The SARS-CoV-2 RBD Fc fusion protein conjugated to HRP was titrated on a 3-fold serial dilution starting at 10 µg/ml.

  • ELISA - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)
    ELISA - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)

    ab273687 binding to immobilized SARS-CoV-2 RBD Fc fusion protein. 96-well plate was coated with the SARS-CoV-2 RBD Fc fusion protein at 5 µg/ml. ab273687 was titrated on a 3-fold serial dilution starting at 10 µg/ml.

  • SDS-PAGE - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)
    SDS-PAGE - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)

    SDS-PAGE analysis of 2.5 µg ab273687.

    Lane 1: Non-reduced.

    Lane 2: Reduced.

  • HPLC - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)
    HPLC - Recombinant Human ACE2 protein (Fc Chimera) (ab273687)

    HPLC analysis of ab273687.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Src (phospho Y529) antibody [Y232] - BSA and Azide free (ab239801)

  •  
  • Product image

    Recombinant human GAPDH protein (Active) (ab82633)

  •  
  • Product image

    Anti-PTP alpha (phospho Y798) antibody [EPR10369] - BSA and Azide free (ab249516)

  •  
  • Product image

    Anti-CDK2 (phospho T160) + CDK1 (phospho T161) antibody [EPR17621] - BSA and Azide free (ab250675)

  •  
  • Product image

    Anti-E Cadherin antibody - BSA and Azide free (Detector) (ab242794)

  •  
  • Product image

    Recombinant Human CPEB3 protein (ab153194)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.